TCBP
Income statement / Annual
Last year (2023), TC Biopharm (Holdings) Plc's total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, TC Biopharm (Holdings) Plc's net income was -$5.91 M.
See TC Biopharm (Holdings) Plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$3.84 M
|
$1.98 M
|
$1.98 M
|
$3.43 M
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$3.84 M |
$1.98 M |
$1.98 M |
$3.43 M |
| Gross Profit Ratio |
0 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$7.77 M
|
$7.59 M
|
$6.16 M
|
$6.68 M
|
$8.61 M
|
| General & Administrative
Expenses |
$6.47 M
|
$8.34 M
|
$3.11 M
|
$2.21 M
|
$3.01 M
|
| Selling & Marketing
Expenses |
$402,314.00
|
$402,314.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.87 M
|
$8.74 M
|
$3.11 M
|
$2.21 M
|
$3.01 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$6.91 M |
$124,901.00 |
$13.52 M |
$8.32 M |
$10.07 M |
| Cost And Expenses |
$6.91 M |
$124,901.00 |
$13.52 M |
$8.32 M |
$10.07 M |
| Interest Income |
$83,025.00 |
$6.75 M |
$3.44 M |
$291,033.00 |
$253,506.00 |
| Interest Expense |
$0.00 |
$6.75 M |
$3.44 M |
$292,062.00 |
$275,410.00 |
| Depreciation &
Amortization |
$630,056.00
|
$762,471.00
|
$811,961.00
|
$878,639.00
|
$721,926.00
|
| EBITDA |
-$13.61 M
|
-$11.32 M
|
-$6.48 M
|
-$5.26 M
|
-$5.92 M
|
| EBITDA Ratio |
0 |
-2.94 |
-3.27 |
-3.04 |
-1.73 |
| Operating Income Ratio
|
0
|
-3.14
|
-3.68
|
-3.48
|
-1.94
|
| Total Other
Income/Expenses Net |
$7.24 M
|
$9.05 M
|
-$7.70 M
|
-$291,033.00
|
-$253,507.00
|
| Income Before Tax |
-$7.00 M |
-$3.03 M |
-$14.98 M |
-$6.63 M |
-$6.89 M |
| Income Before Tax Ratio
|
0
|
-0.79
|
-7.57
|
-3.35
|
-2.01
|
| Income Tax Expense |
-$1.09 M |
$1.72 M |
$1.41 M |
$1.17 M |
$826,065.00 |
| Net Income |
-$5.91 M |
-$1.31 M |
-$13.58 M |
-$5.46 M |
-$6.07 M |
| Net Income Ratio |
0 |
-0.34 |
-6.86 |
-2.76 |
-1.77 |
| EPS |
-191.21 |
-382.31 |
-6951.59 |
-2884.12 |
0 |
| EPS Diluted |
-191.21 |
-382.31 |
-6951.59 |
-2884.12 |
0 |
| Weighted Average Shares
Out |
$30,892.00
|
$3,436.00
|
$1,952.93
|
$1,892.41
|
$1,892.41
|
| Weighted Average Shares
Out Diluted |
$30,892.00
|
$3,436.00
|
$1,952.93
|
$1,892.41
|
$1,892.41
|
| Link |
|
|
|
|
|
